AJR ARRS: Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by King, A. D.
Right arrow Articles by Metreweli, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, A. D.
Right arrow Articles by Metreweli, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2000; 174:209-211
© American Roentgen Ray Society


Original Report

MR Imaging of Nasal T-Cell/Natural Killer Cell Lymphoma

Ann D. King1, Kenny I. K. Lei2, Anil T. Ahuja1, Wynnie W. M. Lam1 and Constantine Metreweli1

1 Department of Diagnostic Radiology and Organ Imaging, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
2 Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.

Received March 19, 1999; accepted after revision June 25, 1999.

 
Address correspondence to A. D. King.


Abstract
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
OBJECTIVE. Nasal T-cell/natural killer cell lymphoma is a distinct clinicopathologic entity derived from natural killer cells. The purpose of the study was to describe the MR features of this rare nasal cavity tumor and correlate MR findings with stage of disease.

CONCLUSION. Nasal T-cell/natural killer cell lymphoma frequently exhibits diffuse invasion of the nasal cavity with necrosis, midline destruction, and extension into the nasopharynx. These features may be seen in both early- and late-stage disease.


Introduction
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Lymphoma of the nasal cavity is a rare tumor, accounting for only 3% of all extranodal non-Hodgkin's lymphomas [1] and 8% of those extranodal lymphomas localized to the head and neck region [2]. The tumor cells frequently express T-cell (T) associated antigens and the natural killer (NK) cell marker, CD56. These findings have led to the subsequent recognition of a distinctive lymphoma subtype called nasal T/NK cell lymphoma [2, 3, 4, 5, 6, 7, 8]. Despite the characteristic pathologic features of nasal T/NK cell lymphoma, difficulty in the diagnosis of nasal T/NK cell lymphoma, both clinically and pathologically, is well recognized. Furthermore, to our knowledge, the MR features of this specific group of lymphomas have not been described. In this study, we document the MR appearances of this rare tumor in seven patients.


Subjects and Methods
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Eight Chinese patients with histologically proven nasal T/NK cell lymphoma were referred to our institution between January 1996 and July 1998. Seven of these patients (five men, two women; age range, 34-63 years; mean, 43 years) underwent MR imaging at presentation. These seven patients with MR examinations constituted the study cohort. Six of the seven patients presented with newly diagnosed primary nasal lymphoma and one presented with relapse isolated to the nasal cavity 3 years after successful treatment for nasopharyngeal lymphoma. Images were obtained on a 1.5-T MR unit (Philips Gyroscan, Eindhoven, the Netherlands) using a head coil (30-cm diameter). All patients underwent an axial T1-weighted spin-echo sequence (TR/TE, 500/20; field of view, 22 cm; slice thickness, 4 mm with no interslice gap; and matrix size, 256 x 202) and a coronal T2-weighted turbo spin-echo sequence (TR/TE, 2500/100; echo train length, 14; field of view, 22 cm; slice thickness, 4 mm with no interslice gap; and matrix size, 256 x 202). In addition, contrast-enhanced T1-weighted spin-echo images were obtained in six patients in the axial (n = 5) and coronal (n = 6) planes after a bolus injection of 0.1 mmol/kg of gadolinium dimeglumine using a 512 x 512 matrix. Scans were reviewed by consensus by two radiologists with knowledge only of the histologic diagnosis. Scans were assessed for tumor signal characteristics, site, volume, and local extent; bone and nasal turbinate destruction; and regional nodes. The MR findings were correlated with the stage of disease.

Endoscopic examination of the nasal cavity, nasopharynx, oropharynx, hypopharynx, and upper aerodigestive tract was performed on all patients. Histologic evaluation and immunohistochemical studies were performed on the biopsy specimens obtained from the tumor. The diagnosis of nasal T/NK cell lymphoma was based on the criteria described by Jaffe et al. [7]. All patients were staged according to the Ann Arbor system [9] with modification for extranodal lymphoma. Clinical staging procedures included complete history and physical examination; complete blood count; blood chemistry studies; serum lactate dehydrogenase level; plain chest radiograph; CT scans of the head, neck, abdomen, and pelvis; and bone marrow aspiration and biopsy. CT of the thorax was performed only after a patient's chest radiograph showed abnormalities. None of the patients underwent a staging laparotomy or lymphangiography.


Results
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
The patients' symptoms at presentation included nasal blockage (n = 5), nasal discharge (n = 5), nasal swelling (n = 2), weight loss (n = 2), fever (n = 2), epistaxis (n = 1), and sore throat (n = 1). Nasal cavity lymphomas were of low to intermediate signal intensity. On T1-weighted images tumors were of homogeneous signal intensity similar or slightly higher than that of the signal intensity of muscle. On T2-weighted images the signal intensity was higher than that of muscle but lower than that of sinonasal mucosa, and was homogeneous in six patients and heterogeneous in one patient in whom the tumor displayed superimposed areas of lower and higher signal intensity. All the tumors in the six patients who received an injection of gadolinium showed moderate enhancement that was greater than that of muscle but less than that of sinonasal mucosa.

There was involvement of both sides of the nasal cavity in five patients and unilateral involvement in two. In the 12 sides of the nasal cavities with disease, tumor was small and localized to one region (n = 2), moderate and localized to more than one region (n = 2), or involved the entire nasal cavity (n = 8). Tumor volume ranged from 5 to 50 cm3 with a mean of 18 cm3. Sites of extension outside the nasal cavity included tumor extension into the nasopharynx (n = 4), oropharynx (n = 1), paranasal sinuses (n = 3), and palate (n = 1). Of the seven patients, three tumors showed areas of necrosis. There was destruction of the nasal turbinates (n = 4), nasal septum (n = 4), and hard palate (n = 1). There was no regional lymphadenopathy The stage of disease was IE, single extranodal organ or site (n = 6); and stage IVE, diffuse or disseminated involvement of one or more distant extranodal sites with or without associated lymph node involvement (n = 1). The one patient with stage IVE disease had disseminated disease to the bone marrow. Large-volume tumors involving both sides of the nasal cavity with extranasal extension, necrosis, and destruction of the nasal turbinates and bone were found in both stages IE and IVE.


Discussion
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Non-Hodgkin's lymphomas of the nasal cavity and nasopharynx are uncommon tumors. Nearly half (45%) of all malignant lymphomas of the nasal cavity and nasopharynx are derived from T/NK cells while 21% are derived from T cells and 34% from B cells [10]. The nasal T/NK cell lymphomas are rare among Western populations but more common in those of Asian descent [4, 5] and are highly associated with Epstein-Barr viral infection [5]. The disease may present clinically as a lethal midline granuloma or midfacial destructive lesion [3, 4] and is known for its predilection for other extranodal sites such as the skin and gastrointestinal tract, highly aggressive course, and poor prognosis [7, 10]. Nasal T/NK cell lymphoma is a distinct clinicopathologic entity with a characteristic immunophenotypic profile of CD2+, CD56+ (natural killer cell marker) and CD3-. The tumor often shows polymorphic lymphoreticular infiltrates and necrosis [11]. Angiocentricity is seen in about half of all cases but is also found in other lymphoma subtypes. In the past the identification of an underlying lymphoma was extremely difficult and many of these cases would have been labelled as polymorphic reticulosis or midline granuloma [12]. Diagnosis is confused further by the large array of other diseases with signs and symptoms that may partly overlap with those of nasal T/NK cell lymphoma. These include malignant midline granuloma, Stewart's granuloma, progressive lethal granulomatous ulceration, malignant midline reticulosis, angiocentric immunoproliferative lesion, and angiocentric lymphoma [13].

In this study, the nasal T/NK cell lymphomas were of intermediate signal intensity on T1- and T2-weighted images (Figs. 1 and 2). The intermediate signal is common for many malignant tumors of the head and neck and contrasts to the very hyperintense signal intensity on T2-weighted images that is found almost exclusively in benign membrane and mucosal diseases. Nasal T/NK cell lymphomas in this study showed a predilection for diffuse invasion of the nasal cavity (Fig. 1), often involving both sides. Even in the smaller volume lymphomas there was a tendency to spread as a diffuse thin sheet of tumor along the walls of the nasal cavity to envelop the nasal turbinates and nasal septum (Fig. 2). In larger volume disease a more discernible mass was seen with destruction of the underlying nasal turbinates (Figs. 3 and 4). Midline destruction of the nasal septum occurred in half of the patients (Fig. 4) and involved the palate in one patient. Destruction of the lateral wall of the nasal cavity was not seen, although in one patient the lymphoma caused bowing of the nasal wall into the maxillary antrum. Tumor necrosis, which is a typical histologic feature of nasal T/NK cell lymphoma [7], was shown on MR imaging in all but one of the patients with a tumor volume of greater than 15 cm3 (Figs. 3 and 4).



View larger version (134K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1 —63-year-old man with nasal T-cell and natural killer cell (T/NK) lymphoma. Axial T1-weighted MR image (TR/TE, 500/20) reveals T/NK cell lymphoma (arrows). Tumor is of intermediate signal intensity in left side of nasal cavity.

 


View larger version (153K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2 —39-year-old man with nasal T-cell and natural killer cell (T/NK) lymphoma. Coronal T2-weighted MR image (TR/TE, 2500/100) shows small T/NK cell lymphoma (arrows) of intermediate signal intensity spreading diffusely along walls of nasal cavity to envelope nasal turbinates.

 


View larger version (158K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3 —34-year-old woman with nasal T-cell and natural killer cell (T/NK) lymphoma. Coronal T1-weighted gadolinium-enhanced MR image (TR/TE, 500/20) shows T/NK cell lymphoma in the right nasal cavity (arrows). Tumor shows destruction of middle turbinate. Solid superior component of tumor shows moderate enhancement and inferior component is necrotic.

 


View larger version (150K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4 —34-year-old man with nasal T-cell and natural killer cell (T/NK) lymphoma. Coronal T1-weighted gadolinium-enhanced MR image (TR/TE, 500/20) reveals midline nasal T/NK cell lymphoma (arrows) with destruction of nasal septum and nasal turbinates. The tumor is predominately necrotic with thin rim of moderately enhancing solid tissue adjacent to more intensely enhancing turbinates and sinonasal mucosa.

 

The T/NK cell lymphomas were confined to the nasal cavity in two patients. The remaining five patients had tumor extensions outside the nasal cavity, most frequently into the nasopharynx. In two of these five patients, a small volume of tumor extended just beyond the nasal cavity into one wall of the nasopharynx. Two patients showed invasion of a wider area of the nasopharynx, and in the fifth patient the lymphoma extended inferiorly into the oropharynx. Invasion of the paranasal sinuses was less common and of smaller volume when compared with those invading into the nasopharynx and oropharynx. Tumor extension superiorly through the cribriform plate into the cranium was not seen. Regional nodal disease was not identified in this study. This was to be expected because nodal involvement in nasal T/NK cell lymphoma is rare and more commonly associated with the B-cell lymphomas [10].

The diagnosis of nasal T/NK-cell lymphoma requires histologic evidence. MR features alone cannot reliably distinguish this tumor from other nasal cavity tumors such as squamous cell carcinoma, minor salivary gland tumor, esthesioneuroblastoma, rhabdomyosarcoma, and lymphoepithelioma. In particular, the aggressive carcinomas, such as adenocarcinoma and undifferentiated carcinoma, can show a similar low to intermediate signal intensity on T1- and T2-weighted images [14] and they are frequently accompanied by bone destruction [15]. Nonneoplastic conditions including Wegener's granulomatosis, sarcoidosis, cocaine abuse, and infections such as leprosy, syphilis, tuberculosis, and fungus may also cause midfacial destruction. However, the differential diagnosis relies more on clinical and laboratory findings than radiologic findings.

In accordance with the literature, most of the patients with nasal NK/T cell lymphomas in this study presented at an early stage with nearly 90% classified as stage IE [5]. Disseminated disease carries a poorer prognosis and was present in one patient (stage IVE). The patient with disseminated disease showed a large-volume necrotic bilateral nasal cavity tumor extending into the paranasal sinuses and nasopharynx with extensive destructive changes in the nasal septum and palate. However, large-volume disease accompanied by necrosis, bone destruction, or extranasal disease was also found in patients with early stage I disease. This limited sample suggests that there may be a disparity between the severity of the radiologic findings and the stage of disease. Further studies will be required to determine the correlation between the extent of tumor, degree of tissue destruction, and tumor volume revealed by MR imaging and the various clinical characteristics, disease stage, and, ultimately, clinical outcome.

In conclusion, patients with nasal T/NK cell lymphoma frequently present with only localized disease. The MR imaging appearance is nonspecific and diagnosis requires histologic confirmation. However, the predilection for T/NK cell lymphoma to cause a diffuse necrotic mass that spreads to the nasopharynx with destruction of the midline structures—the nasal turbinates, nasal septum and palate—are features that in an Asian patient should suggest the diagnosis of nasal T/NK cell lymphoma.


References
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 

  1. Ho FCS, Todd D, Loke SL, Ng RP, Khoo RKK. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period. Int J Cancer 1984;34:143-148[Medline]
  2. Hanna E, Wanamaker J, Adelstein D, Tubbs R, Lavertu P. Extranodal lymphomas of the head and neck: a 20-year experience. Arch Otolaryngol Head Neck Surg 1997;123:1318-1323
  3. Chan JKC, Ng CS, Lau WH, Lo STH. Most nasal/nasopharyngeal lymphomas are peripheral T-cell lymphomas. Am J Surg Pathol 1987;11:418-429[Medline]
  4. Weiss LM, Arber DA, Strickler JG. Nasal T-cell lymphoma. Ann Oncol 1994;10:39-42[Abstract/Free Full Text]
  5. Kwong YL, Chan ACL, Liang R, et al. CD56+ NK lymphomas: clinicopathological features and prognosis. Brit J Haematol 1997;4:821-829
  6. Chan JKC. Peripheral T and natural killer cell lymphomas. Am J Surg Pathol 1997;21:118-119
  7. Jaffe ES, Chan JKC, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103-111[Medline]
  8. Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies (editorial). Blood 1996;87:1207-1210[Free Full Text]
  9. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease classification. Cancer Res 1971;31:1860-1861[Free Full Text]
  10. Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clinical Oncol 1998;16:70-77[Abstract/Free Full Text]
  11. Ferry JA, Sklar J, Zukerberg LR, Harris NL. Nasal lymphoma. A clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol 1991;15:268-279[Medline]
  12. Eichel BS, Harrison EG, Devine KD, Scanlow PW, Brown HA. Primary lymphoma of the nose including a relationship to lethal midline granuloma. Am J Surg 1966;112:597-605[Medline]
  13. Chan JK. Natural killer cell neoplasms. Anat Pathol 1998;3:77-145[Medline]
  14. Som PM, Shapiro MD, Biller HF, Sasaki C, Lawson W. Sinonasal tumors and inflammatory tissues: differentiation with MR imaging. Radiology 1988;167:803-808[Abstract/Free Full Text]
  15. Phillips CD, Futterer SF, Lipper MH, Levine PA. Sinonasal undifferentiated carcinoma: CT and MR imaging of an uncommon neoplasm of the nasal cavity. Radiology 1997;202:477-480[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ImagingHome page
S E J Connor, S Hussain, and E K-F Woo
Sinonasal imaging
Imaging, March 1, 2007; 19(1): 39 - 54.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. M. Kim, Y. H. Park, S.-Y. Lee, J.-H. Kim, D.-W. Kim, S.-A. Im, T.-Y. Kim, C. W. Kim, D. S. Heo, Y.-J. Bang, et al.
Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal type
Blood, December 1, 2005; 106(12): 3785 - 3790.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
H. J. Lee, J.-G. Im, J. M. Goo, K. W. Kim, B. I. Choi, K. H. Chang, J. K. Han, and M. H. Han
Peripheral T-Cell Lymphoma: Spectrum of Imaging Findings with Clinical and Pathologic Features
RadioGraphics, January 1, 2003; 23(1): 7 - 26.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by King, A. D.
Right arrow Articles by Metreweli, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, A. D.
Right arrow Articles by Metreweli, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS